Bionik Laboratories Corp. (BNKL) is a publicly traded company in the Unknown sector. Across all available filings, 6 corporate insiders have executed 31 transactions totaling $1.0M, demonstrating a bullish sentiment with $1.0M in net insider flow. The most recent transaction on Jun 13, 2023 involved a transaction of 186,111 shares valued at $111.7K.
No significant insider buying has been recorded for BNKL in the recent period.
No significant insider selling has been recorded for BNKL in the recent period.
Based on recent SEC filings, insider sentiment for BNKL is bullish with an Insider Alignment Score of 100/100 and a net flow of $1.0M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Bionik Laboratories Corp. (BNKL) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 6 insiders are actively trading BNKL stock, having executed 31 transactions in the past 90 days. The most active insider is Remi Gaston-dreyfus (Executive), who has made 15 transactions totaling $12.0M.
Get notified when executives and directors at BNKL file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jun 13, 2023 | Auberton-herve Andre-jacques | Executive | Conversion | 186,111 | $0.60 | $111.7K | |
| Jun 13, 2023 | Gaston-dreyfus Remi | Executive | Conversion | 3,102,878 | $0.60 | $1.9M | Large |
| Jun 9, 2023 | Auberton-herve Andre-jacques | Executive | Purchase | 650,000 | $0.60 | $390.0K | |
| Jun 9, 2023 | Gaston-dreyfus Remi | Executive | Purchase | 180,555 | $0.60 | $108.3K | |
| Jun 9, 2023 | Matine Charles | Executive | Purchase | 180,555 | $0.60 | $108.3K | |
| Mar 31, 2022 | Gaston-dreyfus Remi | Executive | Conversion | 77,887 | $9.50 | $739.9K | Large |
| Jul 15, 2021 | Auberton-herve Andre-jacques | Executive | Option Exercise | 7,500 | $3.16 | $23.7K | |
| Jul 15, 2021 | Auberton-herve Andre-jacques | Executive | Option Exercise | 51,878 | $3.60 | $186.8K | |
| Jul 15, 2021 | Gaston-dreyfus Remi | Executive | Option Exercise | 5,000 | $N/A | $0 | |
| Jul 15, 2021 | Gaston-dreyfus Remi | Executive | Option Exercise | 115,759 | $N/A | $0 | |
| Mar 29, 2021 | Gaston-dreyfus Remi | Executive | Award | 61,256 | $N/A | $0 | |
| Mar 29, 2021 | Gerald Malone Peter | Executive | Purchase | 26,430 | $N/A | $0 | |
| Mar 29, 2021 | Matine Charles | Executive | Purchase | 26,430 | $N/A | $0 | |
| Mar 29, 2021 | Thevenon Audrey | Executive | Purchase | 26,430 | $N/A | $0 | |
| Mar 29, 2021 | R. Martin Joseph | Executive | Purchase | 26,430 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Conversion(C) | 16 | $13.2M | 91.5% |
Purchase(P) | 10 | $1.0M | 7.0% |
Exercise(M) | 4 | $210.5K | 1.5% |
Award(A) | 1 | $0 | 0.0% |
Insiders at Bionik Laboratories Corp. are accumulating shares at an accelerated pace. With 6 insiders making 31 transactions totaling $1.0M in purchases versus $0 in sales, the net buying activity of $1.0M signals strong executive confidence. Remi Gaston-dreyfus (Executive) leads the buying activity with $12.0M in transactions across all time.